Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Active surveillance for early-stage prostate cancer: defining the triggers for intervention.

Whitson JM, Carroll PR.

J Clin Oncol. 2010 Jun 10;28(17):2807-9. doi: 10.1200/JCO.2010.28.5817. Epub 2010 May 3. No abstract available.

PMID:
20439633
2.

Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention.

Klotz L.

Nat Clin Pract Urol. 2008 Jan;5(1):2-3. Epub 2007 Nov 27. No abstract available.

PMID:
18043601
3.

Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

Malavaud B.

Eur Urol. 2008 Sep;54(3):515-6. doi: 10.1016/j.eururo.2008.06.042. Epub 2008 Jun 20. No abstract available.

PMID:
18585850
4.

Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

Rittmaster R.

Eur Urol. 2008 Sep;54(3):514-5. doi: 10.1016/j.eururo.2008.06.041. Epub 2008 Jun 20. No abstract available.

PMID:
18585846
5.

Prostate specific antigen screening and active surveillance in the elderly.

Konety BR.

J Urol. 2009 Apr;181(4):1534-5. doi: 10.1016/j.juro.2009.01.065. Epub 2009 Feb 23. No abstract available.

PMID:
19230925
6.

Modeling prostate specific antigen kinetics in patients on active surveillance.

Zhang L, Loblaw A, Klotz L.

J Urol. 2006 Oct;176(4 Pt 1):1392-7; discussion 1397-8.

PMID:
16952640
7.

Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer".

Ablin RJ, Sartor O, Bennett CL.

Arch Intern Med. 2010 Aug 9;170(15):1397-9. doi: 10.1001/archinternmed.2010.290. No abstract available.

PMID:
20696969
9.

Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics.

Krakowsky Y, Loblaw A, Klotz L.

J Urol. 2010 Jul;184(1):131-5. doi: 10.1016/j.juro.2010.03.041. Epub 2010 May 15.

PMID:
20478589
10.

Active surveillance for prostate cancer: has the time finally come?

Aragon-Ching JB.

J Clin Oncol. 2010 Jun 1;28(16):e265-6; author reply e267. doi: 10.1200/JCO.2010.28.1584. Epub 2010 Apr 20. No abstract available.

PMID:
20406916
11.

Editorial comment on: Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.

Moul JW, Tang P, Sun L.

Eur Urol. 2010 Mar;57(3):452. doi: 10.1016/j.eururo.2009.03.024. Epub 2009 Mar 13. No abstract available.

PMID:
19303696
12.

Active surveillance: an individualized approach to early prostate cancer.

Klotz L.

BJU Int. 2003 Oct;92(6):657. No abstract available.

13.

Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?

Ploussard G, Salomon L, Xylinas E, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A.

J Urol. 2010 Feb;183(2):539-44. doi: 10.1016/j.juro.2009.10.009. Epub 2009 Dec 14.

14.

Editorial comment.

Suardi N.

J Urol. 2010 Feb;183(2):545. doi: 10.1016/j.juro.2009.10.062. Epub 2009 Dec 14. No abstract available.

PMID:
20006873
15.
16.

Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.

Ercole B, Marietti SR, Fine J, Albertsen PC.

J Urol. 2008 Oct;180(4):1336-9; discussion 1340-1. doi: 10.1016/j.juro.2008.06.027. Epub 2008 Aug 15.

PMID:
18707696
17.

Active surveillance for favorable risk prostate cancer: rationale, risks, and results.

Klotz L.

Urol Oncol. 2007 Nov-Dec;25(6):505-9. Review.

PMID:
18047961
18.

Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.

Hegarty JM, Wallace M, Comber H.

Am J Mens Health. 2008 Jun;2(2):133-42. doi: 10.1177/1557988307300467. Epub 2007 May 23.

PMID:
19477777
19.

Early versus delayed intervention for prostate cancer: the case for early intervention.

Loeb S, Catalona WJ.

Nat Clin Pract Urol. 2007 Jul;4(7):348-9. Epub 2007 Jun 12. No abstract available.

PMID:
17563779
20.

Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression.

Dall'Era MA, Konety BR.

Nat Clin Pract Urol. 2008 May;5(5):277-83. doi: 10.1038/ncpuro1058. Epub 2008 Feb 19. Review.

PMID:
18285752

Supplemental Content

Support Center